Intervention

MK-1029

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

3 shown

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)NCT01656395 · 2012-08-23

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)NCT01624974 · 2012-08-09

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate AsthmaNCT01370317 · 2011-06-01

Common conditions

Leading sponsors

Merck Sharp & Dohme LLC3

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.